This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Companion Animals Vaccines Market

Market Insights on Companion Animals Vaccines covering sales outlook, demand forecast & up-to-date key trends

Companion Animal Vaccines Market, by Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines) & Region - Forecast 2022 - 2028

Global Companion Animals Vaccines Market Snapshot

[220 Pages Report] The market is set to expand 1.4X over the forecast period 2022-2028. The Companion Animals Vaccines Market is expected to grow at a CAGR of 6.9% over the forecast period and record sales worth U.S. $ 4.9 Bn by the end of 2028.

Data Points

Market Insights

Market Value 2022

U.S. $ 3.3 Bn

Market Value 2028

U.S. $ 4.9 Bn

CAGR 2022-2028

6.9%

Share of top 5 countries

56.6%

Key Players

The key players of this industry are Bayer Healthcare, Vétoquinol S.A, Boehringer Ingelheim, Ceva Santé Animale, Eli Lilly and Company (Elcano), Heska Corp., Merck Animal Health, Merial (Sanofi), Virbac and Zoetis (Pfizer).

The global companion animal vaccines market accounts for 31.1% of the global veterinary vaccines market by the end of 2021, which is expected to be valued at the U.S. $ 10.0 Bn in the same year. The growing adoption of companion animals all over the world, humanization of pets and growing awareness of pet insurance are some of the opportunities for the companion animal vaccines market over the forecast period.

Routine vaccine programs for companion animals have eliminated some of the chronic scourges from developed countries. The improved focus on vaccinations campaigns, higher awareness for pet care are fueling the demand for companion animal vaccines. The veterinary healthcare industry is witnessing increased demand for protozoan parasitic vaccines from countries in tropical and sub-tropical regions.

The development of resistance to various chemotherapeutic agents is contributing to increased demand for vaccines over anti-parasitic drugs. In this regard, scientists have noted that the production of third-generation DNA vaccines against protozoan parasites could prove largely helpful. These vaccines are safe as they do not contain any pathogen, are more stable as compared to live attenuated and killed virus in the vaccine and are also cost-effective.

The sales of attenuated live vaccines reached U.S. $ 1.07 Bn by the end of 2021, which would account for 34.3% market share, by the value of the global companion animal vaccines market. The rising incidence of zoonotic diseases is growing awareness about zoonotic diseases and owners are increasingly inclined towards proper care of their pets through effective vaccinations.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

6.85%

H1, 2022 Projected

7.01%

H1, 2022 Outlook

6.91%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(+) 06 ↑

The comparative analysis and market growth rate of global companion animal vaccines market is studied by Future Market Insights. The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 units.

However A positive BPS growth in H1-2022 over H1-2021 by 06 Basis Point Share (BPS) is demonstrated by the market. This increase is due to increasing number of companion animals which has demanded the need for vaccines, thereby impacting the growth of companion animal vaccines market.

Another reason for surge in the market includes increased awareness about zoonotic diseases and government initiatives to curb anti-microbial resistance among pets.

According to FMI analysis, escalation in BPS is attributed to factors such as increase in adoption of recombinant vaccines and also governments involvement in striving to encourage routine vaccination programs of these companion animals inculcating higher awareness for pet care and also fueling the demand for companion animal vaccines.

In India, the rising western influence has increased pet ownership which has demanded growth of pet vaccination and is favoring overall market growth as well.

Factors such as difficulties in understanding of epidemiology of veterinary diseases which hampers the discovery and production limit for a vaccine to prevent the spread of the disease can restrict market growth in the future.

2015-2021 Companion Animals Vaccines Demand Outlook Compared to 2022-2028 Forecast

According to Future Market Insights (FMI), the demand for companion animal vaccines during the period of 2015 to 2021 expanded at a CAGR of 6.5%. A growing number of pets around the world, increasing awareness of the importance of pet vaccination attributed to the growth of this market over the last few years.

According to the North American Pet Health Insurance Association, approximately 2.2 million pets in the U.S. were covered by health insurance in the year 2018, which was 18% more than the number recorded in the previous year. Pet insurance acts as a decision-maker to the companion animal health value chain that includes third-party payers.

The increasing pet insurance coverage in the U.S and other developed countries is expected to act as a value driver to the Global companion animal vaccines market.

Various governments around the world are encouraging pet owners to vaccinate their pets and avoid the unnecessary use of antibiotics for their treatment since there is an increased prevalence of antimicrobial resistance amongst companion animals. Veterinary vaccines reduce reliance on anthelmintic and antimicrobial drugs for treating infections.

Thus, there is an increased demand for pet vaccination around the world. Furthermore, a reduction in overall drug usage among companion animals in developed markets is fueling demand for preventive healthcare tools such as booster vaccines for companion animals.

According to the American Veterinary Medical Association, around 67% of the households in the U.S. owned either dogs, cats, birds or horses as their companions in the year 2018 and on average, a household spent the U.S $ 614 to the U.S. $ 412 on pet care per year.

Since there is such a high number of companion animals in the U.S., the demand for companion animals vaccines is growing at a steady pace and will follow a similar trend over the forecast period.

The COVID-19 pandemic led to many households adopting pets during the lockdown phase. The American Pet Products Association conducted a “COVID-19 Pulse Study”, which concluded that around 11.3 million households in the U.S. got a new pet during the pandemic.

Amongst the correspondents of the study, 16% of the Generation Z respondents, 13% of the millennials and 3% of the baby boomers’ generations either bought or adopted a pet during the lockdown period.

The key players of this industry are focusing on external partnerships in research driving vaccine development, entering into collaborative partnerships, and acquisitions to expand their businesses around the world.

Companion Animals Vaccines Market Download Report Brochure

For instance, in August 2020, Elanco Animal Health Inc. announced the acquisition of the Bayer Animal Health segment. This acquisition enabled Elanco to utilize Bayer’s product range to its full potential during the pandemic by offering the products through online channels, retail sales, telemedicine and doorstep delivery.

In February 2021, Vetoquinol S.A. announced the acquisition of Profender®, which is a spot-on de-wormer product line’s intellectual property rights along with registration and other rights from Elanco Animal Health business in Canada, which was approved by the Canadian Competition Bureau.

The market is consolidated with key players of the companion animal vaccines industry such as Bayer Healthcare, Vétoquinol S.A, Boehringer Ingelheim, Ceva Santé Animale, Eli Lilly and Company (Elcano), Heska Corp., Merck Animal Health, Merial (Sanofi), Virbac and Zoetis (Pfizer).

Future Market Insights expects the global companion animal vaccines market to expand at a CAGR of 6.9% over the forecast period owing to the key player’s various efforts to expand their business around the globe.

What is the impact of COVID-19 on this industry?

The COVID-19 pandemic has had an ambiguous impact on the companion animal vaccines market during the year 2020. The industry experienced stagnation during the first half of 2020 due to lockdown induced reduced patient visits to the veterinary clinics. Moreover, in the latter half of 2020, the market witnessed some steady growth since the lockdown was lifted, the number of client visits to the veterinary hospitals and clinics increased. The increased pet ownership during the lockdown period also had a positive impact on the industry during the pandemic.

Other than the aforementioned impact, the companies manufacturing veterinary vaccines experienced a not so much impact on their sales. For instance, Merck & Co. announced a growth of 7% in their worldwide sales of the animal health segment in 2020.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the key opportunities for manufacturers of companion animal vaccines industry?

Merger & Acquisition activities are gaining a wider footprint within the companion animal vaccines segment in developed markets, which is expected to widen product availability and easy market access. For instance, Elanco Animal Health acquired Kindred Biosciences in August 2021 to expand its product portfolio of dermatology in veterinary medicine and focus on the unmet needs of pet owners and veterinarians.

Many companion animals are relinquished to shelters every year. Due to the increasing growth of companion animals, sterilization is an important process to control overpopulation. This provides an opportunity for companion animal vaccine manufacturers to come up with sterilization vaccines with safety and efficacy, can be suitably administered and undergo secure approvals in countries like the U.S.

The increasing awareness of pet vaccination, zoonotic diseases, along with an increased number of pet ownerships and adoptions can also provide the manufacturers of this industry lucrative opportunities for growth and expansion, especially in the emerging markets.

What are the restraining factors for this market?

Veterinarians have traditionally been responsible for the majority of share of the companion animal products. This share of sales has declined in the U.S, between 2004 and 2014. The shift has moved fast with the introduction of the Fairness to Pet Owners Act in the U.S. Senate in May 2015. This act only allows vets to write prescriptions and allows owners to buy the medicine and vaccines from retailers or pharmacies.

This change requires the companion animal vaccine players to change their strategies of targeting vets and shift to other important stakeholders i.e. pharmacists and retailers. This shift is expected to divert the traditional revenue distribution and veterinary clinic consolidation resulting in affecting the profit margin distribution due to changes in stakeholders.

There exists a large gap in understanding the epidemiology pattern of veterinary diseases due to variations in disease patterns for endemic countries. A typical example is one for Newcastle Disease for poultry and other birds, where the lack of epidemiological knowledge creates a serious economic loss.

Virulent Newcastle disease virus (vNDV) is evolving simultaneously at different locations due to isolates that are distributed worldwide and mutate rapidly. This leads to large knowledge gaps in the development of multiple vNDV genotypes. This hampers the discovery and production limit for a vaccine to prevent the spread of the disease. Recurrent infection in birds allows the maintenance of a reservoir for the viruses.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Will the U.S. remain a key market for companion animal vaccines?

The U.S. hold around 75.4% market share, by revenue of the total market in North America in the year 2021. The companion animal vaccines market is expected to expand at a CAGR of 7.4% in the U.S. over the forecast period (2022-2028). Availability of pet insurance, awareness of zoonotic diseases, government initiatives to curb the anti-microbial resistance amongst pets is some of the factors that attribute to this large share of the U.S.

Why Germany is considered a more lucrative market within Western Europe?

Around 21% of the German households owned a dog and approximately 26% of the households owned a cat in Germany, as of 2020. This is one of the key factors contributing to the growth of the companion animal vaccines market in Germany, which is set to expand at a CAGR of 11.5% over the forecast period (2022-2028). The sales for this industry is valued at U.S. $ 172.9 Mn in the year 2021 in Germany.

What are the factors supporting the sales of companion animal vaccines in India?

India held nearly a 9.1% market share, by revenue in the Asia Pacific market for companion animal vaccines in 2021. The market in India is expected to expand at a CAGR of 5.9% over the forecast period (2022-2028). The increasing influence of western culture came with the increased interest in pet ownership in India. It is estimated that the population of pet dogs in India is expected to be somewhere around 31 million by the end of 2023.

What is the demand outlook of companion animal vaccines in Japan?

The demand for companion animal vaccines in Japan is expected to expand at a CAGR of 6.8% over the forecast period (2022-2028) and is expected to hold a 10.9% market share, by revenue of the global market in 2022. The sales of this market in Japan are expected to be the U.S. $ 364.4 Mn in the year 2022.

Category-wise Insights

What is the companion animal vaccines market value?

The companion animal vaccines market is expected to record sales worth U.S. $ 3.3 Bn in the year 2022 and is set to be U.S. $ 4.98 Bn by the end 0f 2028, which depicts a cumulative CAGR of 6.9% over the forecast period.

Why is the demand for attenuated live vaccines the highest, by product?

Live vaccines use attenuated (or weakened) forms of bacteria that cause the target disease. These vaccines are so similar to natural infections that they help prevent them by producing a strong, long-term immune response. Because of their high efficacy against all diseases, the demand for them is the highest. The sales of attenuated live vaccines are anticipated to be the U.S. $ 1.15 Bn in the year 2022 and are set to expand at a cumulative CAGR of 7.4% over the forecast period.

Why is canine accounting for the highest share, by species type?

The sales for companion animal vaccines by the canine segment are expected to be the U.S. $ 1.69 Bn in the year 2022 and this segment is set to expand at a CAGR of 7.0% over the forecast period (2022-2028). Canine is anticipated to hold 50.9% market share, by revenue of the global market in 2022. According to the World Atlas pet ownership statistics, dogs are ranked first in the list of most popular pets in the U.S. with approximately 48,255,413 households owning a pet dog as of August 2020.

Which distribution channel holds the maximum share in the companion animal vaccines market?

Veterinary Clinics are expected to hold 41.8% market share by revenue of the global companion animal vaccines market in the year 2022 and are set to record sales worth U.S. $ 1.39 Bn in the same year. Since the majority of pet owners prefer visiting a clinic for their pet’s vaccinations, this segment holds such a high share in the market, because they are cost-efficient in comparison to the hospitals.

Competitive Landscape

The key players of this industry are focusing their efforts on mergers and acquisitions, strategic partnerships, investments in research and development to expand their market presence worldwide.

In August 2021, Zoetis announced its plan to acquire Jurox, a private animal health company from Australia. With the completion of this acquisition, Zoetis will be able to capitalize on Jurox’s varied product range and expand its business globally. Since Australia is Zoetis’s fifth-largest revenue-making market, according to their annual report of 2020, this acquisition will help the company strengthen their market presence even further in the country.

Merck Animal Health announced the formation of a strategic partnership with The Street Dog Coalition in the U.S. in January 2021, to provide them with vaccines, medications and treatment of homeless pets.

In October 2021, Boehringer Ingelheim announced a 100 Mn euros investment to expand its veterinary vaccine capacity in France. This investment was made to help the government in France manage the highly contagious transboundary and emerging diseases in animals which may affect public health in the country.

Scope of the Report:

Attributes

Details

Forecast Period

2022-2028

Historic Data available for

2015-2021

Market Analysis

USD Million for value

Key Countries covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa.

Key Segments covered

Product Type, Distribution Channel, Species Type & Region.

Key Companies Profiled

  • Bayer Healthcare
  • Vétoquinol S.A
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Eli Lilly and Company (Elcano)
  • Heska Corp.
  • Merck Animal Health
  • Merial (Sanofi)
  • Virbac
  • Zoetis (Pfizer)

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization and Pricing

Available upon request

Companion Animals Vaccines Market, By Category

Product Type:

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Distribution Channel:

  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies & Others

Species Type:

  • Canine
  • Avian
  • Feline

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • The Asia Pacific except Japan
  • Japan
  • Middle East and Africa

Frequently Asked Questions

The companion animal vaccines industry recorded sales worth U.S. $ 3.11 Bn in the year 2021 and is set to be U.S. $ 4.98 Bn by the end of 2028, which depicts a cumulative CAGR of 6.9% over the forecast period.

The market value of the global animal vaccines market is the U.S. $ 3.11 Bn in the year 2021.

The rising incidence of zoonotic diseases, increased pet ownership, growing awareness of pet vaccination, availability of pet insurances are some of the major factors driving the global companion animals vaccines market growth.

North America holds the largest market share, by revenue of the global companion animal vaccines market with the recorded sales of U.S. $ 935.2 Mn in the year 2021.

The companion animal vaccines market grew at a CAGR of nearly 6.5% from 2015 to 2021.

Table of Content

1. Executive Summary

2. Market Introduction

    2.1. Companion Animal Vaccines Market Definition

    2.2. Companion Animal Vaccines Market Taxonomy

    2.3. Veterinary Vaccines Market

3. Companion Animal Vaccines Market Analysis Scenario

    3.1. Regulations and Reimbursement Scenario

    3.2. Global Company Market Share Analysis (2021)

    3.3. Mechanism for Veterinary Product Approval

    3.4. Companion Animal Vaccines Market Overview

        3.4.1. List of Active Participants

4. Companion Animal Vaccines Market Dynamics

    4.1. Macro-economic Factors

    4.2. Drivers

        4.2.1. Supply Side

        4.2.2. Demand Side

    4.3. Restraints

    4.4. Opportunity

    4.5. Global Trends

5. Global Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028, By Product Type

    5.1. Introduction

        5.1.1. Basis Point Share (BPS) Analysis By Product Type

        5.1.2. Y-o-Y Growth Projections By Product Type

    5.2. Market Size (US$ Mn) 2015-2028, Forecast By Product Type

        5.2.1. Attenuated Live Vaccines

        5.2.2. Conjugate Vaccines

        5.2.3. Inactivated Vaccines

        5.2.4. Subunit Vaccines

        5.2.5. Toxoid Vaccines

        5.2.6. DNA Vaccines

        5.2.7. Recombinant Vaccines

    5.3. Market Attractiveness Analysis By Product Type

    5.4. Prominent Trends

6. Global Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028, By Distribution Channel

    6.1. Introduction

        6.1.1. Basis Point Share (BPS) Analysis By Distribution Channel

        6.1.2. Y-o-Y Growth Projections By Distribution Channel

        6.1.3. Comparative Analysis By Distribution Channel

    6.2. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel

        6.2.1. Veterinary Clinics

        6.2.2. Veterinary Hospitals

        6.2.3. Veterinary Research Institutes

        6.2.4. Retail Pharmacies & Others

    6.3. Market Attractiveness Analysis By Distribution Channel

    6.4. Prominent Trends

7. Global Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028, By Species Type

    7.1. Introduction

        7.1.1. Basis Point Share (BPS) Analysis By Species Type

        7.1.2. Y-o-Y Growth Projections By Species Type

        7.1.3. Comparative Analysis By Species Type

    7.2. Market Size (US$ Mn) 2015-2028,  Forecast By Species Type

        7.2.1. Canine

        7.2.2. Avian

        7.2.3. Feline 

    7.3. Market Attractiveness Analysis By Species Type

8. Global Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028, By Region

    8.1. Introduction

        8.1.1. Basis Point Share (BPS) Analysis By Region

        8.1.2. Y-o-Y Growth Projections By Region

    8.2. Market Size (US$ Mn) 2015-2028, Forecast By Region

        8.2.1. North America

        8.2.2. Latin America

        8.2.3. Western Europe

        8.2.4. Eastern Europe

        8.2.5. Asia Pacific Excl. Japan (APEJ)

        8.2.6. Japan

        8.2.7. Middle East and Africa (MEA)

    8.3. Market Attractiveness Analysis By Region

9. North America Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028

    9.1. Introduction

        9.1.1. Basis Point Share (BPS) Analysis By Country

        9.1.2. Y-o-Y Growth Projections By Country

        9.1.3. Key Regulations

    9.2. Market Size (US$ Mn) 2015-2028, and Volume (Units) 2015-2028,  Forecast By Country

        9.2.1. U.S.

        9.2.2. Canada

    9.3. Market Size (US$ Mn) 2015-2028,  Forecast By Product Type

        9.3.1. Attenuated Live Vaccines

        9.3.2. Conjugate Vaccines

        9.3.3. Inactivated Vaccines

        9.3.4. Subunit Vaccines

        9.3.5. Toxoid Vaccines

        9.3.6. DNA Vaccines

        9.3.7. Recombinant Vaccines

    9.4. Market Size (US$ Mn) 2015-2028,  Forecast By Distribution Channel

        9.4.1. Veterinary Clinics

        9.4.2. Veterinary Hospitals

        9.4.3. Veterinary Research Institutes

        9.4.4. Retail Pharmacies & Others

    9.5. Market Size (US$ Mn) 2015-2028,  Forecast By Species Type

        9.5.1. Canine

        9.5.2. Avian

        9.5.3. Feline 

    9.6. Market Attractiveness Analysis

        9.6.1. By Country

        9.6.2. By Product Type

        9.6.3. By Distribution Channel

        9.6.4. By Species Type

10. Latin America Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028

    10.1. Introduction

        10.1.1. Basis Point Share (BPS) Analysis By Country

        10.1.2. Y-o-Y Growth Projections By Country

        10.1.3. Key Regulations

    10.2. Market Size (US$ Mn) 2015-2028, and Volume (Units) 2015-2028,  Forecast By Country

        10.2.1. Brazil

        10.2.2. Mexico

        10.2.3. Rest of Latin America

    10.3. Market Size (US$ Mn) 2015-2028,  Forecast By Product Type

        10.3.1. Attenuated Live Vaccines

        10.3.2. Conjugate Vaccines

        10.3.3. Inactivated Vaccines

        10.3.4. Subunit Vaccines

        10.3.5. Toxoid Vaccines

        10.3.6. DNA Vaccines

        10.3.7. Recombinant Vaccines

    10.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel

        10.4.1. Veterinary Clinics

        10.4.2. Veterinary Hospitals

        10.4.3. Veterinary Research Institutes

        10.4.4. Retail Pharmacies & Others

    10.5. Market Size (US$ Mn) 2015-2028,  Forecast By Species Type

        10.5.1. Canine

        10.5.2. Avian

        10.5.3. Feline 

    10.6. Market Attractiveness Analysis

        10.6.1. By Country

        10.6.2. By Product Type

        10.6.3. By Distribution Channel

        10.6.4. By Species Type

11. Western Europe Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028

    11.1. Introduction

        11.1.1. Basis Point Share (BPS) Analysis By Country / Region

        11.1.2. Y-o-Y Growth Projections By Country

        11.1.3. Key Regulations

    11.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country / Region

        11.2.1. Germany

        11.2.2. France

        11.2.3. Italy

        11.2.4. Spain

        11.2.5. U.K.

        11.2.6. BENELUX

        11.2.7. Rest of Western Europe

    11.3. Market Size (US$ Mn) 2015-2028,  Forecast By Product Type

        11.3.1. Attenuated Live Vaccines

        11.3.2. Conjugate Vaccines

        11.3.3. Inactivated Vaccines

        11.3.4. Subunit Vaccines

        11.3.5. Toxoid Vaccines

        11.3.6. DNA Vaccines

        11.3.7. Recombinant Vaccines

    11.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel

        11.4.1. Veterinary Clinics

        11.4.2. Veterinary Hospitals

        11.4.3. Veterinary Research Institutes

        11.4.4. Retail Pharmacies & Others

    11.5. Market Size (US$ Mn) 2015-2028,  Forecast By Species Type

        11.5.1. Canine

        11.5.2. Avian

        11.5.3. Feline 

    11.6. Market Attractiveness Analysis

        11.6.1. By Country

        11.6.2. By Product Type

        11.6.3. By Distribution Channel

        11.6.4. By Species Type

12. Eastern Europe Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028

    12.1. Introduction

        12.1.1. Basis Point Share (BPS) Analysis By Country

        12.1.2. Y-o-Y Growth Projections By Country

        12.1.3. Key Regulations

    12.2. Market Size (US$ Mn) 2015-2028, and Volume (Units) 2015-2028,  Forecast By Country

        12.2.1. Russia

        12.2.2. Poland

        12.2.3. Rest of Eastern Europe

    12.3. Market Size (US$ Mn) 2015-2028,  Forecast By Product Type

        12.3.1. Attenuated Live Vaccines

        12.3.2. Conjugate Vaccines

        12.3.3. Inactivated Vaccines

        12.3.4. Subunit Vaccines

        12.3.5. Toxoid Vaccines

        12.3.6. DNA Vaccines

        12.3.7. Recombinant Vaccines

    12.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel

        12.4.1. Veterinary Clinics

        12.4.2. Veterinary Hospitals

        12.4.3. Veterinary Research Institutes

        12.4.4. Retail Pharmacies & Others

    12.5. Market Size (US$ Mn) 2015-2028,  Forecast By Species Type

        12.5.1. Canine

        12.5.2. Avian

        12.5.3. Feline 

    12.6. Market Attractiveness Analysis

        12.6.1. By Country

        12.6.2. By Product Type

        12.6.3. By Distribution Channel

        12.6.4. By Species Type

13. Asia Pacific Excl. Japan (APEJ) Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028

    13.1. Introduction

        13.1.1. Basis Point Share (BPS) Analysis By Country / Region

        13.1.2. Y-o-Y Growth Projections By Country / Region

        13.1.3. Key Regulations

    13.2. Market Size (US$ Mn) 2015-2028, and Volume (Units) 2015-2028,  Forecast By Country

        13.2.1. China

        13.2.2. India

        13.2.3. ASEAN

        13.2.4. Australia and New Zealand

        13.2.5. Rest of APEJ

    13.3. Market Size (US$ Mn) 2015-2028,  Forecast By Product Type

        13.3.1. Attenuated Live Vaccines

        13.3.2. Conjugate Vaccines

        13.3.3. Inactivated Vaccines

        13.3.4. Subunit Vaccines

        13.3.5. Toxoid Vaccines

        13.3.6. DNA Vaccines

        13.3.7. Recombinant Vaccines

    13.4. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel

        13.4.1. Veterinary Clinics

        13.4.2. Veterinary Hospitals

        13.4.3. Veterinary Research Institutes

        13.4.4. Retail Pharmacies & Others

    13.5. Market Size (US$ Mn) 2015-2028, Forecast By Species Type

        13.5.1. Canine

        13.5.2. Avian

        13.5.3. Feline 

    13.6. Market Attractiveness Analysis

        13.6.1. By Country

        13.6.2. By Product Type

        13.6.3. By Distribution Channel

        13.6.4. By Species Type

14. Japan Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028

    14.1. Introduction

        14.1.1. Key Regulations

    14.2. Market Size (US$ Mn) 2015-2028, Forecast By Product Type

        14.2.1. Attenuated Live Vaccines

        14.2.2. Conjugate Vaccines

        14.2.3. Inactivated Vaccines

        14.2.4. Subunit Vaccines

        14.2.5. Toxoid Vaccines

        14.2.6. DNA Vaccines

        14.2.7. Recombinant Vaccines

    14.3. Market Size (US$ Mn) 2015-2028, Forecast By Distribution Channel

        14.3.1. Veterinary Clinics

        14.3.2. Veterinary Hospitals

        14.3.3. Veterinary Research Institutes

        14.3.4. Retail Pharmacies & Others

    14.4. Market Size (US$ Mn) 2015-2028,  Forecast By Species Type

        14.4.1. Canine

        14.4.2. Avian

        14.4.3. Feline 

    14.5. Market Attractiveness Analysis

        14.5.1. By Product Type

        14.5.2. By Distribution Channel

        14.5.3. By Species Type

15. MEA Companion Animal Vaccines Market Analysis 2015-2021 and Forecast 2022-2028

    15.1. Introduction

        15.1.1. Basis Point Share (BPS) Analysis By Country

        15.1.2. Y-o-Y Growth Projections By Country

        15.1.3. Key Regulations

    15.2. Market Size (US$ Mn) 2015-2028, Forecast By Country

        15.2.1. GCC Countries

        15.2.2. South Africa

        15.2.3. Rest of MEA

    15.3. Market Size (US$ Mn) 2015-2028, Forecast By Product Type

        15.3.1. Attenuated Live Vaccines

        15.3.2. Conjugate Vaccines

        15.3.3. Inactivated Vaccines

        15.3.4. Subunit Vaccines

        15.3.5. Toxoid Vaccines

        15.3.6. DNA Vaccines

        15.3.7. Recombinant Vaccines

    15.4. Market Size (US$ Mn) 2015-2028,  Forecast By Distribution Channel

        15.4.1. Veterinary Clinics

        15.4.2. Veterinary Hospitals

        15.4.3. Veterinary Research Institutes

        15.4.4. Retail Pharmacies & Others

    15.5. Market Size (US$ Mn) 2015-2028, Forecast By Species Type

        15.5.1. Canine

        15.5.2. Avian

        15.5.3. Feline 

    15.6. Market Attractiveness Analysis

        15.6.1. By Country

        15.6.2. By Product Type

        15.6.3. By Distribution Channel

        15.6.4. By Species Type

16. Competition Landscape

    16.1. Competition Dashboard

    16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

    16.3. Global Players

        16.3.1. Bayer Healthcare

            16.3.1.1. Overview

            16.3.1.2. Financials

            16.3.1.3. Strategy

            16.3.1.4. Recent Developments

        16.3.2. Vétoquinol S.A

            16.3.2.1. Overview

            16.3.2.2. Financials

            16.3.2.3. Strategy

            16.3.2.4. Recent Developments

        16.3.3. Boehringer Ingelheim

            16.3.3.1. Overview

            16.3.3.2. Financials

            16.3.3.3. Strategy

            16.3.3.4. Recent Developments

        16.3.4. Ceva

            16.3.4.1. Overview

            16.3.4.2. Financials

            16.3.4.3. Strategy

            16.3.4.4. Recent Developments

        16.3.5. Eli Lilly and Company (Elcano) 

            16.3.5.1. Overview

            16.3.5.2. Financials

            16.3.5.3. Strategy

            16.3.5.4. Recent Developments

        16.3.6. Heska Co.

            16.3.6.1. Overview

            16.3.6.2. Financials

            16.3.6.3. Strategy

            16.3.6.4. Recent Developments

        16.3.7. Merck Animal Health

            16.3.7.1. Overview

            16.3.7.2. Financials

            16.3.7.3. Strategy

            16.3.7.4. Recent Developments

        16.3.8. Merial (Sanofi)

            16.3.8.1. Overview

            16.3.8.2. Financials

            16.3.8.3. Strategy

            16.3.8.4. Recent Developments

        16.3.9. Virbac

            16.3.9.1. Overview

            16.3.9.2. Financials

            16.3.9.3. Strategy

            16.3.9.4. Recent Developments

        16.3.10. Zoetis (Pfizer)

            16.3.10.1. Overview

            16.3.10.2. Financials

            16.3.10.3. Strategy

            16.3.10.4. Recent Developments

17. Assumptions and Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Companion Animal Vaccines Market Value Forecast, By Product Type, 2022-2028 (US$ Mn)

Table 2: Global Companion Animal Vaccines Market Value Forecast, By Distribution Channel, 2022-2028 (US$ Mn)

Table 3: Global Companion Animal Vaccines Market Value Forecast, By Species Type, 2022-2028 (US$ Mn)

Table 4: Global Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Region, 2022-2028

Table 5: North America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028

Table 6: North America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028

Table 7: North America Companion Animal Vaccines Market Value Forecast, By Species Type, 2022-2028 (US$ Mn)

Table 8: North America Companion Animal Vaccines Market Value Forecast, By Country, 2022-2028 (US$ Mn)

Table 9: Latin America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028

Table 10: Latin America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028

Table 11: Latin America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028

Table 12: Latin America Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028

Table 13: Western Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028

Table 14: Western Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028

Table 15: Western Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028

Table 16: Western Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028

Table 17: Eastern Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028

Table 18: Eastern Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028

Table 19: Eastern Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028

Table 20: Eastern Europe Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028

Table 21: APEJ Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028

Table 22: APEJ Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028

Table 23: APEJ Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028

Table 24: APEJ Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028

Table 25: Japan Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028

Table 26: Japan Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028

Table 27: Japan Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028

Table 28: MEA Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Product Type, 2022-2028

Table 29: MEA Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Distribution Channel, 2022-2028

Table 30: MEA Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Species Type, 2022-2028

Table 31: MEA Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Country, 2022-2028

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Companion Animal Vaccines Market Share, by Species Type, 2022 (E)

Figure 2: Global Companion Animal Vaccines Market Share, by Product Type, 2022 (E)

Figure 3: Global Companion Animal Vaccines Market Share, by Distribution Channel, 2022 (E)

Figure 4: Market Share of Prominent Key Players: Companion Animal Vaccines Market, 2021

Figure 5: Global Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028

Figure 6: Global Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2021-2028

Figure 7: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Attenuated Live Vaccines, 2022-2028

Figure 8: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Conjugate Vaccines, 2022-2028

Figure 9: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Inactivated Vaccines, 2022-2028

Figure 10: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Subunit Vaccines, 2022-2028

Figure 11: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Toxoid Vaccines, 2022-2028

Figure 12: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By DNA Vaccines, 2022-2028

Figure 13: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Recombinant Vaccines, 2022-2028

Figure 14: Global Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028

Figure 15: Global Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028

Figure 16: Global Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028

Figure 17: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Veterinary Clinics, 2022-2028

Figure 18: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Veterinary Hospitals, 2022-2028

Figure 19: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Veterinary Research Institutes, 2022-2028

Figure 20: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Retail Pharmacies, 2022-2028

Figure 21: Global Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028

Figure 22: Global Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028

Figure 23: Global Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028

Figure 24: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Canine, 2022-2028

Figure 25: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Avian, 2022-2028

Figure 26: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Feline, 2022-2028

Figure 27: Global Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028

Figure 28: Global Companion Animal Vaccines Share Analysis (%) By Region, 2022 & 2028

Figure 29: Global Companion Animal Vaccines Share Analysis (%) By Region, 2022 & 2028

Figure 30: Global Companion Animal Vaccines Market Attractiveness Analysis, By Region, 2022-2028

Figure 31: North America Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028

Figure 32: North America Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2022-2028

Figure 33: North America Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028

Figure 34: North America Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028

Figure 35: North America Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028

Figure 36: North America Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028

Figure 37: North America Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028

Figure 38: North America Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028

Figure 39: North America Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028

Figure 40: North America Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028

Figure 41: North America Companion Animal Vaccines Y-o-Y growth (%) By Country, 2021-2028

Figure 42: North America Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028

Figure 43: Latin America Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028

Figure 44: Latin America Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2022-2028

Figure 45: Latin America Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028

Figure 46: Latin America Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028

Figure 47: Latin America Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028

Figure 48: Latin America Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028

Figure 49: Latin America Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028

Figure 50: Latin America Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028

Figure 51: Latin America Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028

Figure 52: Latin America Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028

Figure 53: Latin America Companion Animal Vaccines Y-o-Y growth (%) By Country, 2021-2028

Figure 54: Latin America Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028

Figure 55: Western Europe Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028

Figure 56: Western Europe Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2022-2028

Figure 57: Western Europe Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028

Figure 58: Western Europe Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028

Figure 59: Western Europe Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028

Figure 60: Western Europe Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028

Figure 61: Western Europe Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028

Figure 62: Western Europe Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2022-2028

Figure 63: Western Europe Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028

Figure 64: Western Europe Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028

Figure 65: Western Europe Companion Animal Vaccines Y-o-Y growth (%) By Country, 2022-2028

Figure 66: Western Europe Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028

Figure 67: Eastern Europe Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028

Figure 68: Eastern Europe Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2021-2028

Figure 69: Eastern Europe Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028

Figure 70: Eastern Europe Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028

Figure 71: Eastern Europe Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028

Figure 72: Eastern Europe Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028

Figure 73: Eastern Europe Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028

Figure 74: Eastern Europe Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028

Figure 75: Eastern Europe Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028

Figure 76: Eastern Europe Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028

Figure 77: Eastern Europe Companion Animal Vaccines Y-o-Y growth (%) By Country, 2021-2028

Figure 78: Eastern Europe Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028

Figure 79: APEJ Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028

Figure 80: APEJ Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2022-2028

Figure 81: APEJ Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028

Figure 82: APEJ Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028

Figure 83: APEJ Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028

Figure 84: APEJ Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028

Figure 85: APEJ Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028

Figure 86: APEJ Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028

Figure 87: APEJ Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028

Figure 88: APEJ Companion Animal Vaccines Share Analysis (%) By Country, 2022 & 2028

Figure 89: APEJ Companion Animal Vaccines Y-o-Y growth (%) By Country, 2021-2028

Figure 90: APEJ Companion Animal Vaccines Market Attractiveness Analysis, By Country, 2022-2028

Figure 91: Japan Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028

Figure 92: Japan Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2021-2028

Figure 93: Japan Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028

Figure 94: Japan Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028

Figure 95: Japan Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028

Figure 96: Japan Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028

Figure 97: Japan Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028

Figure 98: Japan Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028

Figure 99: Japan Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028

Figure 100: MEA Companion Animal Vaccines Share Analysis (%) By Product Type, 2022 & 2028

Figure 101: MEA Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2021-2028

Figure 102: MEA Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2022-2028

Figure 103: MEA Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2022 & 2028

Figure 104: MEA Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2021-2028

Figure 105: MEA Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2022-2028

Figure 106: MEA Companion Animal Vaccines Share Analysis (%) By Species Type, 2022 & 2028

Figure 107: MEA Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2021-2028

Figure 108: MEA Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2022-2028

Figure 109: MEA Companion Animal Vaccines Share Analysis (%) By Country/Region, 2022 & 2028

Figure 110: MEA Companion Animal Vaccines Y-o-Y growth (%) By Country/Region, 2021-2028

Figure 111: MEA Companion Animal Vaccines Market Attractiveness Analysis, By Country/Region, 2022-2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Veterinary Molecular Diagnostics Market

Published : December 2021

Healthcare

Companion Animal Specialty Drugs Market

Published : August 2021

Healthcare

Companion Animal Drugs Market

Published : October 2019

Healthcare

Animal Healthcare Market

Published : September 2017

Google translate

Companion Animals Vaccines Market